SK280298B6 - Izochinolíny, spôsob ich prípravy, farmaceutické p - Google Patents
Izochinolíny, spôsob ich prípravy, farmaceutické p Download PDFInfo
- Publication number
- SK280298B6 SK280298B6 SK1319-94A SK131994A SK280298B6 SK 280298 B6 SK280298 B6 SK 280298B6 SK 131994 A SK131994 A SK 131994A SK 280298 B6 SK280298 B6 SK 280298B6
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- isoquinoline
- ester
- acid
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939322828A GB9322828D0 (en) | 1993-11-05 | 1993-11-05 | Organic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
SK131994A3 SK131994A3 (en) | 1995-06-07 |
SK280298B6 true SK280298B6 (sk) | 1999-11-08 |
Family
ID=10744697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1319-94A SK280298B6 (sk) | 1993-11-05 | 1994-11-03 | Izochinolíny, spôsob ich prípravy, farmaceutické p |
Country Status (26)
Country | Link |
---|---|
US (1) | US5747506A (it) |
EP (1) | EP0664289A3 (it) |
JP (1) | JPH07188176A (it) |
KR (1) | KR950014073A (it) |
CN (1) | CN1051998C (it) |
AT (1) | AT404940B (it) |
AU (1) | AU685852B2 (it) |
CA (1) | CA2135000A1 (it) |
CH (1) | CH688478A5 (it) |
CZ (1) | CZ282329B6 (it) |
DE (1) | DE4438737A1 (it) |
FI (1) | FI945191A (it) |
FR (1) | FR2711989B1 (it) |
GB (2) | GB9322828D0 (it) |
HK (1) | HK1005776A1 (it) |
HU (1) | HU217120B (it) |
IL (1) | IL111518A (it) |
IT (1) | IT1273993B (it) |
NO (1) | NO302293B1 (it) |
NZ (1) | NZ264851A (it) |
PE (1) | PE30395A1 (it) |
PL (1) | PL178210B1 (it) |
RU (1) | RU2144027C1 (it) |
SK (1) | SK280298B6 (it) |
TW (1) | TW353067B (it) |
ZA (1) | ZA948738B (it) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9312853D0 (en) | 1993-06-22 | 1993-08-04 | Euro Celtique Sa | Chemical compounds |
US5591776A (en) | 1994-06-24 | 1997-01-07 | Euro-Celtique, S.A. | Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
US5922751A (en) | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
US6166041A (en) | 1995-10-11 | 2000-12-26 | Euro-Celtique, S.A. | 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma |
US6075016A (en) | 1996-04-10 | 2000-06-13 | Euro-Celtique S.A. | 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity |
ID19155A (id) * | 1996-12-13 | 1998-06-18 | Tanabe Seiyaku Co | Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya |
US5919794A (en) * | 1998-05-11 | 1999-07-06 | Virginia Commonwealth University | Methods of using pharmaceutical tetrahydroisoquinolines |
US6200771B1 (en) * | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
IL132407A0 (en) * | 1998-10-21 | 2001-03-19 | Pfizer Prod Inc | Method for treating congestive heart failure |
DE19930614A1 (de) * | 1999-07-02 | 2001-01-04 | Mann & Hummel Filter | Filtereinsatz |
CA2381802C (en) | 1999-08-21 | 2010-12-07 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Synergistic combination of roflumilast and salmeterol |
JP2003526677A (ja) * | 2000-03-14 | 2003-09-09 | ザ・ユニバーシテイ・オブ・ウエスタン・オンタリオ | 骨形成に影響を与える組成物および方法 |
AU2002224835A1 (en) * | 2000-11-14 | 2002-05-27 | Byk Gulden Lomberg Chemische Fabrik G.M.B.H. | Dihydroisoquinolines as novel phosphodiesterase inhibitors |
NZ525147A (en) | 2000-11-14 | 2004-10-29 | Altana Pharma Ag | (Dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
DE10229762A1 (de) * | 2002-07-03 | 2004-01-22 | Aventis Pharma Deutschland Gmbh | Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
EA200501548A1 (ru) | 2003-04-01 | 2006-02-24 | Апплайд Резеч Системз Арс Холдинг Н.В. | Ингибиторы фосфодиэстераз при бесплодии |
US7795385B2 (en) * | 2004-12-17 | 2010-09-14 | Bexar Global, Inc. | Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
EP2170930B3 (en) | 2007-06-04 | 2013-10-02 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
JP2011522828A (ja) | 2008-06-04 | 2011-08-04 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
AU2009270833B2 (en) | 2008-07-16 | 2015-02-19 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
PL2366699T3 (pl) * | 2008-10-02 | 2013-12-31 | Asahi Kasei Pharma Corp | 8-podstawiona pochodna izochinoliny i jej zastosowanie |
JP6265583B2 (ja) | 2008-10-17 | 2018-01-24 | ウィスコンシン アルムニ リサーチ ファンデイション | 生理活性アルファベータペプチドを作製する方法 |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
DK2681236T3 (en) | 2011-03-01 | 2018-04-16 | Synergy Pharmaceuticals Inc | PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS |
EP2958577A2 (en) | 2013-02-25 | 2015-12-30 | Synergy Pharmaceuticals Inc. | Guanylate cyclase receptor agonists for use in colonic cleansing |
WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
EP3004138B1 (en) | 2013-06-05 | 2024-03-13 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
AU2014305843B2 (en) | 2013-08-09 | 2019-08-29 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
US20200368223A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Methods for inhibiting phosphate transport |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB645139A (en) * | 1946-10-22 | 1950-10-25 | Servita Gyogyszeryar Es Vegyip | Improved process for the production of isoquinoline derivatives |
GB1400425A (en) * | 1971-09-22 | 1975-07-16 | Rolland Sa A | Substituted 3-hydroxymethyl-isoquinolines and derivatives |
US3878215A (en) * | 1971-12-01 | 1975-04-15 | Sandoz Ag | 2-Alkyl-3-substituted-4-aryl isoquinolines |
US4018927A (en) * | 1973-12-17 | 1977-04-19 | The Regents Of The University Of Michigan | Treatment of proliferating skin diseases with papaverine alkaloids |
KR840002104B1 (ko) * | 1980-08-08 | 1984-11-15 | 부자 앙드레 | 신규 이소퀴놀린 유도체의 제법 |
HU183479B (en) * | 1981-06-16 | 1984-05-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing new 6,7-diethoxy-1-aracket-4-ethoxy-3-hydroxy-benzyl-bracket closed-3,4-dihydroisoquinolin |
DE3244594A1 (de) * | 1982-12-02 | 1984-06-07 | Hoechst Ag, 6230 Frankfurt | 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung |
GB8328052D0 (en) * | 1983-10-20 | 1983-11-23 | Beecham Group Plc | Compounds |
US4761403A (en) * | 1986-04-09 | 1988-08-02 | Abbott Laboratories | Lipoxygenase inhibiting compounds |
HU196758B (en) * | 1986-05-21 | 1989-01-30 | Gyogyszerkutato Intezet | Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them |
CA1330560C (en) * | 1986-05-21 | 1994-07-05 | Maurits E. A. Vandewalle | Di- and tetrahydroisoquinoline derivatives |
GB8800397D0 (en) * | 1988-01-08 | 1988-02-10 | Sandoz Ltd | Improvements in/relating to organic compounds |
GB9027055D0 (en) * | 1990-12-13 | 1991-02-06 | Sandoz Ltd | Organic compounds |
-
1993
- 1993-11-05 GB GB939322828A patent/GB9322828D0/en active Pending
-
1994
- 1994-10-28 FR FR9413108A patent/FR2711989B1/fr not_active Expired - Fee Related
- 1994-10-28 CH CH03226/94A patent/CH688478A5/de not_active IP Right Cessation
- 1994-10-29 DE DE4438737A patent/DE4438737A1/de not_active Withdrawn
- 1994-11-01 GB GB9421985A patent/GB2283488B/en not_active Expired - Fee Related
- 1994-11-01 EP EP94810628A patent/EP0664289A3/en not_active Withdrawn
- 1994-11-03 CA CA002135000A patent/CA2135000A1/en not_active Abandoned
- 1994-11-03 SK SK1319-94A patent/SK280298B6/sk unknown
- 1994-11-03 AU AU77610/94A patent/AU685852B2/en not_active Ceased
- 1994-11-03 IL IL11151894A patent/IL111518A/xx active IP Right Grant
- 1994-11-03 NO NO944187A patent/NO302293B1/no not_active IP Right Cessation
- 1994-11-03 NZ NZ264851A patent/NZ264851A/en unknown
- 1994-11-03 IT ITRM940706A patent/IT1273993B/it active IP Right Grant
- 1994-11-03 PE PE1994254101A patent/PE30395A1/es not_active Application Discontinuation
- 1994-11-03 FI FI945191A patent/FI945191A/fi unknown
- 1994-11-03 CZ CZ942698A patent/CZ282329B6/cs not_active IP Right Cessation
- 1994-11-03 KR KR1019940028732A patent/KR950014073A/ko not_active Application Discontinuation
- 1994-11-04 RU RU94040170A patent/RU2144027C1/ru active
- 1994-11-04 AT AT0204894A patent/AT404940B/de not_active IP Right Cessation
- 1994-11-04 ZA ZA948738A patent/ZA948738B/xx unknown
- 1994-11-04 HU HU9403184A patent/HU217120B/hu not_active IP Right Cessation
- 1994-11-04 CN CN94118199A patent/CN1051998C/zh not_active Expired - Fee Related
- 1994-11-04 JP JP6271172A patent/JPH07188176A/ja active Pending
- 1994-11-04 PL PL94305705A patent/PL178210B1/pl unknown
- 1994-11-16 TW TW083110617A patent/TW353067B/zh active
-
1996
- 1996-12-20 US US08/771,556 patent/US5747506A/en not_active Expired - Lifetime
-
1998
- 1998-06-03 HK HK98104801A patent/HK1005776A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK280298B6 (sk) | Izochinolíny, spôsob ich prípravy, farmaceutické p | |
CS375791A3 (en) | Novel dihydroisoquinoline derivatives | |
SK283562B6 (sk) | 8-Aryl-1,7-naftyridínové deriváty, farmaceutické prostriedky, ktoré ich obsahujú, ich použitie, spôsob ich prípravy a medziprodukty použité v tomto spôsobe | |
WO2005063732A1 (en) | Compounds and methods for the treatment of asthma | |
US20040147544A1 (en) | Pde4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases | |
JPH0649686B2 (ja) | イソキノリン誘導体、その製法および用途 | |
JPH0631236B2 (ja) | 新規キサンチン誘導体 | |
EP1030844A1 (en) | Compounds which inhibit tryptase activity | |
SK63998A3 (en) | Quinoline derivatives, method for the preparation thereof, pharmaceutical composition containing same, and their use | |
WO2007106706A1 (en) | Cyclic urea compounds as soluble epoxide hydrolase inhibitors effective for the treatment of cardiovascular disorders | |
JP2021515811A (ja) | 3”,5”−ジアルコシベンゾイル−3’−アミノ−3’−デオキシアデノシン−5’−三リン酸及びその医薬用途 | |
US20040167153A1 (en) | Pharmaceutical combination | |
EP0410446A1 (en) | (S)-5-hydroxydecanoic acid and its therapeutic composition | |
SG173463A1 (en) | Dimeric pyrrolopyrimidinedione and its use in therapy of respiratory diseases | |
IE911542A1 (en) | New pharmaceutical use of benzocycloheptathiophenecarboxylic¹acid derivatives | |
JP2000038382A (ja) | 新規ベンゾフラノン誘導体及びその製造方法 | |
AU2002344167A1 (en) | A PDE 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases |